Nutraceuticals and Probiotics
Performance and gut health supplements for livestock and poultry, reducing antibiotic dependence through microbiome management.
Antibiotic resistance is forcing a rethink of livestock production. Nutraceuticals are the most evidence-based alternative available.
Ceva Santé Animale's nutraceutical and probiotic range supports gut health, immune function and performance in livestock and commercial poultry without antibiotic dependence. Products include direct-fed microbials, organic acid blends, prebiotic substrates, mycotoxin binders and transition cow hepatic support, deployed at weaning, transition, transport stress and throughout high-risk production periods.
Direct-fed microbials
Ceva's DFM products deliver Bacillus-based probiotic strains that compete with pathogens for mucosal binding sites, produce organic acids that lower intestinal pH and stimulate innate immune function. In broiler production, DFM inclusion reduces Campylobacter and Salmonella caecal counts by 1-2 log10.
Mycotoxin binders
Aflatoxin B1 contamination of maize, groundnut cake and cottonseed cake is endemic in East Africa. Ceva's mycotoxin binder range adsorbs aflatoxin, fumonisin and zearalenone in the gastrointestinal tract before systemic absorption, protecting liver function and maintaining vaccine efficacy.
Transition cow support
The 3 weeks before and after calving are the highest metabolic stress period in the dairy cow's cycle. Ceva's transition cow nutraceutical programme, combining propylene glycol precursors, choline, niacin and hepatic support products, reduces metabolic disease incidence by 20-35% in documented trials.
Antibiotic regulations are tightening. Alternatives must perform.
Kenya, Uganda and Tanzania are tightening veterinary antibiotic use regulations under One Health AMR action plans. Commercial poultry and dairy operations relying on in-feed antibiotics for growth promotion will face procurement barriers within this decade. Probiotics, prebiotics, organic acids and phytogenics are the documented alternative that maintains performance without antibiotic dependence.
Mycotoxin contamination is a silent cost in East Africa.
Surveys of maize and groundnut cake in Kenya, Uganda and Tanzania consistently find aflatoxin B1 above 20 ppb, the threshold for measurable immunosuppression in cattle and poultry. Animals on contaminated feed respond poorly to vaccines and have suppressed milk and weight gain performance. Mycotoxin binders are one of the highest-ROI nutritional interventions when feed contamination is confirmed.
Weaning is the highest-risk window for gut health.
The shift from milk to solid feed disrupts gut microbiome composition, reduces villous height and creates an enteropathogen susceptibility window that drives post-weaning diarrhoea in pigs and calves. Probiotic and prebiotic supplementation starting 5 days before weaning and continued for 14 days after reduces post-weaning diarrhoea incidence by 30-50% in East African field trials.
Technical specifications.
Product categories
DFM probiotics, mycotoxin binders, organic acids, prebiotic substrates, transition cow products
Target species
Cattle, poultry (broiler/layer), pigs, small ruminants
Key applications
Gut health, mycotoxin protection, transition support, weaning, antibiotic reduction
Probiotic strains
Bacillus subtilis, B. licheniformis, Enterococcus faecium
Mycotoxins bound
Aflatoxin B1, fumonisin B1/B2, zearalenone, DON
Manufacturer
Ceva Sante Animale (France), global animal health leader
Reduction in post-weaning diarrhoea incidence with probiotic and prebiotic supplementation protocol at weaning
Reduction in caecal Salmonella and Campylobacter counts with direct-fed microbial inclusion in broiler diets
Reduction in transition cow metabolic disease incidence with Ceva nutraceutical pre- and post-calving programme
Why Nutraceuticals.
Antibiotic reduction pathway
Evidence-based alternatives that maintain performance as veterinary antibiotic regulations tighten across East Africa.
Mycotoxin protection
Adsorbs aflatoxin, fumonisin and zearalenone before systemic absorption, protecting liver function and vaccine response.
Ceva global research base
France-based global animal health company with extensive field trial data across Africa and tropical production systems.
Integrated protocol support
Jos•Hansen technical team builds integrated nutraceutical protocols, not single-product prescriptions.
Partner with Jos Hansen
Talk to our procurement and operations teams about your next infrastructure, healthcare or scientific deployment.